This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Daniel George, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
        • A Patient Journey
          Alicia Morgans, MD, MPH
          Charles J. Ryan, MD
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
  • Transformative Evidence
    • mCRPC
      • CARD Trial
      • PROfound Study
    • mHSPC
      • ENZAMET Trial
    • nmCRPC
      • PROSPER Trial
    • Advanced Prostate Cancer
      • HERO Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO 2019
        • ASCO 2020
        • ASCO GU 2020
        • ESMO 2020
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA Annual Meeting 2019
        • PCF 2019
        • SNMMI Curriculum
      • UroToday Exclusives
        • A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
        • Book Club
        • Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
        • COVID-19 and Genitourinary Cancers Videos
        • Large Urology Group Practice Association (LUGPA)
        • Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
    • Urologic Oncology
      • Bladder Cancer
        • Bladder Cancer
        • Bladder Cancer Expert Debates
        • Advanced Bladder Cancer
        • Non-Muscle Invasive Bladder Cancer
      • Kidney Cancer
        • Advanced Kidney Cancer
        • Renal Cancer
      • Prostate Cancer
        • Advances in Nuclear Medicine, PET, and Theranostics
        • Advanced Prostate Cancer
        • Cardiovascular Disease in Men with Prostate Cancer
        • CRPC with Bone Metastases
        • The Expert Voice
        • Imaging: Prostate Cancer
        • Localized Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • The Patient Voice
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Upper Tract Urothelial Tumors
        • Upper Tract Urothelial Carcinoma
    • Pelvic Health & Reconstruction
      • Bladder Health
      • Indwelling Catheters
      • Intermittent Catheters
      • Nocturia & Lower Urinary Tract Conditions
    • Endourology
      • Endourology Today
      • Endourology
  • Journals
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
      • From the Editor
      • Current Issue
      • Previous Issues
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
      • From the Editor
      • Current Article
      • Previous Articles
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 APCCC Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2020 Virtual Education Program
      • 2020 Annual Meeting
      • 2020 ASCO GU Symposium
      • 2019 Annual Meeting
      • 2019 ASCO GU Symposium
    • American Urological Association (AUA)
      • 2020 Annual Meeting
      • 2019 Annual Meeting
    • ANZUP Mini Annual Scientific Meeting (ASM)
      • 2020 Virtual Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2020 Think Tank Virtual Program
      • 2019 Think Tank
    • Canadian Urological Association (CUA)
      • 2019 CUOS Summit
    • Clinical Conference
      • 2019 American College of Surgeons
    • EMUC
      • 2020 Annual Meeting
    • European Association of Urology (EAU)
      • 2020 Annual Congress
      • 2019 Annual Congress
      • ESOU 2019
    • Enhanced Recovery After Surgery (ERAS)
      • 2019 ERAS Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2020 Virtual Congress
      • 2019 Annual Congress
    • Global Society of Rare GU Tumors
      • 2020 Meeting
    • International Bladder Cancer Network (IBCN)
      • 2020 Annual Virtual Meeting
      • 2019 Meeting
    • Prostate Cancer Academy
      • 2020 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2020 Annual Congress
      • 2019 Annual Congress
    • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
      • 2019 Therapeutics Conference
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2020 Congress
      • 2019 Congress
    • Society of Urologic Oncology (SUO)
      • 2020 Annual Meeting
      • 2020 SUO - AUA Summer Webcast
      • 2019 Annual Meeting
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
    • World Congress of Endourology and SWL (WCE)
      • 2019 Annual Meeting
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • COVID-19 and Genitourinary Cancers
      • COVID-19 and Genitourinary Cancers
  • Calendar
  1. UroToday Home
  2. Conference Highlights

ESMO 2019

  • Prostate Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Testicular Cancer

ESMO 2019

ESMO 2019 Prostate Cancer

  • ESMO 2019: Overall Survival Interim Analysis Results of the Phase 3 SPARTAN Trial
  • ESMO 2019: Invited Discussant - Phase 3 PROfound Study for Metastatic Castration-resistant Prostate Cancer (LBA12)
  • ESMO 2019: Treatment of Pelvic Node-Positive Prostate Cancer: Systemic Treatment: The Role of Chemotherapy and Androgen Receptor Targeted Therapy
  • ESMO 2019: Treatment of Pelvic Node-Positive Prostate Cancer: Is there a Role for Radical Surgery?
  • ESMO 2019: Treatment of Pelvic Node-Positive Prostate Cancer: Advances in Pelvic Nodal Radiotherapy
View all (63 articles)

ESMO 2019 Kidney Cancer

  • ESMO 2019: Invited Discussant: (911PD and 912PD) New Anti-Angiogenic Treatments for Kidney Cancer
  • ESMO 2019: Patients with Advanced Renal Cell Carcinoma with Sarcomatoid Histology: A Subgroup Analysis on Efficacy and Biomarkers from the Phase 3 JAVELIN Renal 101 Trial of First-Line Avelumab plus Axitinib versus Sunitinib
  • ESMO 2019: Results from a Global Patient Survey: Diagnosis, Management, and Burden of Renal Cell Carcinomas - A Medical Oncologist’s Perspective
  • ESMO 2019: ADAPTeR: Anti-PD1 Therapy as Operative Therapy in Metastatic Renal Cell Carcinoma
  • ESMO 2019: Results of the Phase 2 TRAXAR Study: A Randomized Phase 2 Trial of Axitinib and TRC105 (TRAX) versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma
View all (37 articles)

ESMO 2019 Bladder Cancer

  • ESMO 2019: Invited Discussant: IMvigor130: Phase III Study of Atezolizumab with or without Platinum-Based Chemotherapy in Previously Untreated Metastatic Urothelial Carcinoma
  • ESMO 2019: EV-103 Enfortumab Vedotin plus Pembrolizumab for Urothelial Carcinoma
  • ESMO 2019: Invited Discussant: How Do the Results of IMvigor130 Change Things in Bladder Cancer?
  • ESMO 2019: Invited Discussant: Results of the IMVigor130 Study of Atezoluzumab as Monotherapy, or in Combination with Platinum Chemotherapy for Patients with Advanced or Metastatic Urothelial Carcinoma
  • ESMO 2019: IMvigor130: Efficacy and Safety of Atezolizumab as Monotherapy or Combined with Platinum-based Chemotherapy vs Placebo + Platinum-based Chemotherapy in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma
View all (31 articles)

ESMO 2019 Testicular Cancer

  • ESMO 2019: Invited Discussant: Testicular and Kidney Cancer (913PD - APACHE (Testicular), 914PD (Testicular) , and 915PD (RCC))
  • ESMO 2019: Prognostic Factors in Metastatic Seminomatous Germ Cell Tumors and Elevated HCG – a Study of the G3
  • ESMO 2019: APACHE: An Open Label, Randomized, Phase 2 Study of Durvalumab, Alone or in Combination with Tremelimumab, in Patients with Refractory Germ Cell Tumors: Results from the Expanded Combination Therapy Cohort 
  • ESMO 2019: Prognostic Factors in Metastatic Seminomatous Germ Cell Tumors and Elevated Human Chorionic Gonadotrophin – Study of the G3
  • ESMO 2019: APACHE: An Open Label, Randomized, Phase II Study of Durvalumab Alone or in Combination with Tremelimumab, in Patients with Refractory Germ Cell Tumors: Results from the Expanded Combination Therapy Cohort
View all (7 articles)
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2021 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free